| Literature DB >> 29382388 |
Dereje Dengela1, Aklilu Seyoum2, Bradford Lucas2, Benjamin Johns2, Kristen George3, Allison Belemvire3, Angela Caranci3, Laura C Norris3, Christen M Fornadel3.
Abstract
BACKGROUND: Indoor residual spraying (IRS) is the application of insecticide to the interior walls of household structures that often serve as resting sites for mosquito vectors of malaria. Human exposure to malaria vectors is reduced when IRS involves proper application of pre-determined concentrations of the active ingredient specific to the insecticide formulation of choice. The impact of IRS can be affected by the dosage of insecticide, spray coverage, vector behavior, vector susceptibility to insecticides, and the residual efficacy of the insecticide applied. This report compiles data on the residual efficacy of insecticides used in IRS campaigns implemented by the United States President's Malaria Initiative (PMI)/United States Agency for International Development (USAID) in 17 African countries and compares observed length of efficacy to ranges proposed in World Health Organization (WHO) guidelines. Additionally, this study provides initial analysis on variation of mosquito mortality depending on the surface material of sprayed structures, country spray program, year of implementation, source of tested mosquitoes, and type of insecticide.Entities:
Keywords: Alpha-cypermethrin; Bendiocarb; Deltamethrin; IRS; Insecticide resistance; Malaria; PMI; Pirimiphos-methyl CS; Residual bioassay; USAID
Mesh:
Substances:
Year: 2018 PMID: 29382388 PMCID: PMC5791726 DOI: 10.1186/s13071-017-2608-4
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
IRS coverage in Africa
| Year | Total population protected by IRS in Africa | Total population protected through PMI support in Africa | % population protected with PMI support |
|---|---|---|---|
| 2010 | 78 million | 27,199,063 | 35 |
| 2011 | 77 million | 28,344,173 | 36 |
| 2012 | 58 million | 30,297,000 | 52 |
| 2013 | 55 million | 21,801,615 | 40 |
| 2014 | 50 million | 18, 270,723 | 37 |
Residual bio-efficacy in months of insecticides from routine program monitoring, WHO guidelines, and previous studies
| Insecticide | Range of residual efficacy from program monitoringa | Suggested residual efficacy per WHO reportb | Residual efficacy found in other studiesc |
|---|---|---|---|
| Alpha-cypermethrin WP | 4–10 ( | 4–6 | • Up to 14 (plastic coated plywood), < 1 (cement) in Sao Tome and Principe [ |
| Deltamethrin WG | 1–10 ( | 3–6 | • 6.5 (concrete), 5 (mud) and 3.8 (wood) in Cameroon [ |
| Bendiocarb WP | < 1–7 ( | 2–6 | • 1.5 (red clay and mixture of red clay and cement) and 1.75 (mixture of sand and cement) in Benin [ |
| Pirimiphos-methyl CS | 2–9 ( | 4–6 | • 9 months in Benin [ |
| Pirimiphos-methyl EC | 2 ( | 2–3 | na |
aSource: Authors’ calculations from field collected data
bSources: [32, 34]
cSources as listed. (n = the number of test observations included in the current dataset)
dFor alpha-cypermethrin SC;
ealpha-cypermethrin WP and WG; doses of 20 mg/m2 and 30 mg/ m2; no significant difference was observed between the two formulations and dosages
f50, 40 and 25 mg/m2 dosages, respectively; tested on laboratory-reared Anopheles stephensi strain
gAedes aegypti and Aedes albopictus strains
hDosage of 0.5 g/m2
Fig. 1Residual bio-efficacy of alpha-cypermethrin sprayed on different surface types measured using WHO cone bioassays 2008–2012 in Ghana, Kenya and Mozambique. ^: data label designates instances where testing was ended before mosquito mortality fell below the WHO mortality cut-off of 80%
Fig. 2Residual bio-efficacy of deltamethrin sprayed on different surface types measured using WHO cone bioassays 2010–2015 in Africa. ^: data label designates instances where testing was ended before mosquito mortality fell below the WHO mortality cut-off of 80%
Fig. 3Residual bio-efficacy of bendiocarb sprayed on different surface types measured using WHO cone bioassays 2010–2015 in East Africa. ^: data label designates instances where testing was ended before mosquito mortality fell below the WHO mortality cut-off of 80%
Fig. 4Residual bio-efficacy of bendiocarb sprayed on different surface types measured using WHO cone bioassays 2008–2014 in West Africa. ^: data label designates instances where testing was ended before mosquito mortality fell below the WHO mortality cut-off of 80%
Fig. 5Residual bio-efficacy of pirimiphos-methyl sprayed on different surface types measured using WHO cone bioassays 2010–2015 in East and West Africa. ^: data label designates instances where testing was ended before mosquito mortality fell below the WHO mortality cut-off of 80%